TriMas Corp (NASDAQ:TRS) CFO Robert J. Zalupski sold 2,600 shares of TriMas stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $31.33, for a total transaction of $81,458.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Shares of NASDAQ TRS opened at $31.27 on Thursday. The firm has a market cap of $1.41 billion, a price-to-earnings ratio of 17.58, a PEG ratio of 3.51 and a beta of 1.35. The company has a quick ratio of 1.61, a current ratio of 2.92 and a debt-to-equity ratio of 0.49. TriMas Corp has a 52-week low of $25.18 and a 52-week high of $33.45. The business’s 50 day moving average is $30.66 and its two-hundred day moving average is $30.27.

TriMas (NASDAQ:TRS) last announced its earnings results on Monday, November 4th. The industrial products company reported $0.44 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.06). The firm had revenue of $236.80 million during the quarter, compared to analysts’ expectations of $241.92 million. TriMas had a net margin of 8.46% and a return on equity of 12.68%. The firm’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.48 EPS. Analysts anticipate that TriMas Corp will post 1.78 EPS for the current fiscal year.

A number of hedge funds and other institutional investors have recently made changes to their positions in TRS. Susquehanna International Group LLP purchased a new stake in shares of TriMas during the second quarter worth $486,000. Fiduciary Management Inc. WI increased its position in shares of TriMas by 11.8% during the second quarter. Fiduciary Management Inc. WI now owns 3,035,065 shares of the industrial products company’s stock worth $93,996,000 after acquiring an additional 319,943 shares during the period. First Trust Advisors LP increased its position in shares of TriMas by 61.6% during the second quarter. First Trust Advisors LP now owns 143,563 shares of the industrial products company’s stock worth $4,446,000 after acquiring an additional 54,739 shares during the period. AMI Investment Management Inc. increased its position in shares of TriMas by 3.8% during the third quarter. AMI Investment Management Inc. now owns 115,320 shares of the industrial products company’s stock worth $3,535,000 after acquiring an additional 4,245 shares during the period. Finally, Zions Bancorporation N.A. increased its position in shares of TriMas by 7.0% during the second quarter. Zions Bancorporation N.A. now owns 6,943 shares of the industrial products company’s stock worth $215,000 after acquiring an additional 455 shares during the period. 97.13% of the stock is currently owned by institutional investors.

Several analysts have recently commented on TRS shares. BidaskClub raised shares of TriMas from a “hold” rating to a “buy” rating in a research report on Wednesday, October 30th. Zacks Investment Research raised shares of TriMas from a “sell” rating to a “hold” rating and set a $31.00 price target on the stock in a research report on Tuesday, August 20th.

About TriMas

TriMas Corporation manufactures and sells products for consumer products, aerospace, industrial, petrochemical, refinery, and oil and gas end markets worldwide. It operates in three segments: Packaging, Aerospace, and Specialty Products. The Packaging segment designs, manufactures, and sells specialty closure products, including steel and plastic drum closures, plastic pail dispensers and plugs, and plastic enclosures; specialty dispensing products, such as foamers, lotion pumps, fine mist sprayers, airless dispensers, and other packaging solutions for the cosmetic, personal care, and household product markets; and specialty plastic closures for bottles and jars in the food and beverage markets under the Rieke name.

Featured Story: Profit Margin

Insider Buying and Selling by Quarter for TriMas (NASDAQ:TRS)

Receive News & Ratings for TriMas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriMas and related companies with MarketBeat.com's FREE daily email newsletter.